News-Medical.Net January 18, 2023
By Pooja Toshniwal Paharia Reviewed by Danielle Ellis, B.Sc.

In a recent perspective published in Nature Medicine, the researcher shared his vision and future perspectives for the domains of clinical research and evidence-based therapeutics.

Background

In recent times, advancements in technological wearables, machine learning, and data mining have initiated the transformation of evidence-based medical practices to revolutionize next-generation trials and treatments. Despite scientific advances in technology, the clinical translation of medicinal achievements is lacking. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has exposed existing clinical trial limitations and improved trial design by increasing focus on the prime subject of research, i.e., the patient.

About the perspective

In the present perspective, the researcher envisioned the future of clinical research, emphasizing key areas of improvement in clinical trial design,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Clinical Trials, Digital Health, Technology, Trends, Wearables
Medtronic, Tempus testing AI to find potential TAVR patients
Legal and ethical challenges in AI-driven clinical trials
Biohaven muscle drug misses goal of SMA study, but advances in obesity
Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose
Will Walgreens’ store closures disrupt its clinical trial aims?

Share This Article